CHARLES SCHWAB INVESTMENT MANAGEMENT INC - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 105 filers reported holding VISTAGEN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 12.86 and the average weighting 0.3%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$61,667
+39.9%
494,520
+15.6%
0.00%
Q4 2022$44,078
-33.2%
427,9390.0%0.00%
Q3 2022$66,000
-86.1%
427,939
-20.9%
0.00%
Q2 2022$476,000
-30.6%
540,747
-2.3%
0.00%
Q1 2022$686,000
-27.6%
553,201
+14.0%
0.00%
Q4 2021$947,000
-28.8%
485,417
+0.1%
0.00%
Q3 2021$1,330,000
-11.0%
485,104
+2.3%
0.00%
Q2 2021$1,495,000
+1297.2%
474,361
+853.0%
0.00%
Q1 2021$107,00049,7770.00%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Henrickson Nauta Wealth Advisors, Inc. 200,000$24,9400.02%
GSA CAPITAL PARTNERS LLP 1,275,215$1590.02%
TKG Advisors, LLC 134,860$16,8170.01%
JOHNSON & JOHNSON 190,494$23,7550.01%
GPS Wealth Strategies Group, LLC 253,205$31,5750.01%
Performa Ltd (US), LLC 90,000$11,2230.01%
Jackson Wealth Management, LLC 23,850$2,9740.00%
Garden State Investment Advisory Services LLC 30,000$3,7410.00%
MAI Capital Management 584,925$72,9400.00%
Twin Lakes Capital Management, LLC 12,500$1,5590.00%
View complete list of VISTAGEN THERAPEUTICS INC shareholders